Europe – Notified body official shares recommendations for successful PMCF plans
Successful postmarket clinical follow-up plans (PMCFs) should be able to provide new information that was not previously known about a device, such as delayed...
Europe – MDCG 2022 – 5 Rev. 1 Guidance on borderline between medical devices...
The demarcation between the Regulation (EU) 2017/745 on medical devices (MDR) on
the one hand and the Directive 2001/83/EC on the Community code relating to...
Europe – MDCG 2024-13 Regulatory status of ethylene oxide (EtO) intended for the...
The regulatory status of ethylene oxide (EtO) for the sterilisation of single-use medical devices during the manufacturing process has been discussed in relation to...
UK – UK’s Medical Device Post-market Surveillance Statutory Instrument Laid Before Parliament – What...
On 21 October 2024, the UK Government laid the draft Post-market Surveillance statutory instrument (“PMS SI”) before Parliament (see the UK Medicines and Healthcare products Regulatory Agency’s...
Europe – EMA official reports on scientific advice pilots for high-risk and orphan devices
A European Medicines Agency (EMA) official provided an update on the agency’s pilot programs aimed delivering scientific advice to manufacturers of high-risk and orphan...
Europe – Team-NB views on implementation of MDR/IVDR Regulations
At the Team-NB general assembly meeting, held on October 9th, the members aligned on a
strategy including operational aspects to respond to the concerns regarding...
Europe – Urgent need to revise the medical devices regulation
The European Parliament,
– having regard to the Treaty on the Functioning of the European Union, and in particular
Article 168 thereof,
– having regard to Regulation...
France – La HAS émet un avis favorable à l’octroi d’un forfait innovation pour...
Le diagnostic de l’endométriose peut s’avérer difficile lorsque l’examen clinique en 1re intention et le bilan d’imagerie en 2e intention produisent des résultats discordants. L’utilisation d’Endotest...
Europe – Stakeholders disagree over need for ‘urgent action’ on MDR/IVDR
As medtech companies work to comply with the European Union’s Medical Device Regulation (MDR) and In Vitro Diagnostics Regulation (IVDR), stakeholders disagree on whether...
UK – Implementation of medical devices future regime : Implementation of the future regulations...
The government intends to introduce new regulations for medical devices that prioritise patient safety, give patients access to the medical devices they need and...
